Sorted By:


PhRMA Statement on GAO Report

PhRMA  |  Press Release

Unfortunately, medicines are always looked at as a cost and never seen as a savings, even though medicines often reduce unnecessary hospitalizations, help avoid costly medical procedures and increase productivity through better prevention and management of chronic diseases.

PhRMA Announces Dr. Richard Moscicki as New Chief Medical Officer and Executive Vice President

PhRMA  |  Press Release

“Rich’s deep medical, academic, clinical regulatory and private sector expertise will be invaluable as we seek to advance public policies in the United States and around the world that support medical innovation.”

PhRMA urges CMS to share the savings with seniors

PhRMA  |  Blog Post

In fact, from 2010 to 2015, these rebates increased nearly 24 percent per year, about twice as fast as total Part D drug costs, with manufacturer rebates accounting for the bulk of that growth.

More Than 50 Medicines and Vaccines in Development for HIV Infection, Treatment and Prevention

PhRMA  |  Press Release

“While we are excited for the robust pipeline in the treatment and prevention of HIV/AIDS, and patients’ lives continue to improve, it’s still crucial that we increase awareness and education about the virus, stress the importance of getting tested and seek to end the stigma associated with HIV/AIDS.”

Innovation Spotlight: Collaboration Fueling Biopharmaceutical Advancements

PhRMA  |  Video

Biopharmaceutical innovation in California’s Bay Area is bringing about new research, high-skilled talent and a collaborative ecosystem fueling the nation’s next set of scientific discoveries.

PhRMA Member Companies Invested $49.5 Billion In Research and Development in 2011

PhRMA  |  Press Release

“Part of that story is our shift to a more agile sector, which increasingly involves collaborative, constructive partnerships with both public and private experts.”

Lessons learned: Clinical trials

PhRMA  |  Blog Post

(@pfizer) May 5, 2016 Have you ever thought about participating in a .com/hashtag/clinicaltrial?

Free Trade Agreements May Be Good For Your Health

PhRMA  |  Blog Post

As negotiators from the 12 participating countries in the TPP seek to wrap up talks in the coming weeks, they would be well served to take note of the positive impact that innovative biopharmaceutical companies have had on global patient health.

Kady H.

From Hope To Cures  |  From Our Network

Having been a part of numerous clinical trials over the past several years, she has seen what the future of type 1 diabetes looks like – and the future is promising.

New Blood Tests, Liquid Biopsies, May Transform Cancer Care

From Hope To Cures  |  From Our Network

"I spent most of my life giving drugs that were useless to people" because there was no good way to tell who would benefit or quickly tell when one wasn't working, she said.

People Behind the Science

PhRMA  |  From PhRMA

See their stories below.

PhRMA Statement on Industry Support of Medical Education

PhRMA  |  Press Release

“In fact, continuing medical education (CME) is just one source of information helpful to physicians, however.

Oncology is on the Leading Edge of Personalized Medicine

Chartpack  |  From Our Network

In ten years, cancer patients have seen a four-fold increase in their personalized medicine treatment options.

How a Competitive Biopharmaceutical Marketplace Helps to Control Costs

PhRMA  |  Blog Post

  Our nation’s competitive marketplace is why we have seen such tremendous – and sustainable - progress against hepatitis C, cancer and other challenging diseases.

Medicare Monday: What is IPAB, and why is it bad for patients?

PhRMA  |  Blog Post

  Stakeholders across the health care sector – including hospitals, doctors, patient groups and senior groups – have raised concerns with IPAB.

Highlighting innovation during Mental Illness Awareness Week 2015

PhRMA  |  Blog Post

As our knowledge of the brain continues to expand, biopharmaceutical scientists are finding new, exciting ways to help patients facing depression, schizophrenia and many other disorders .

Progress Treating Disease

PhRMA  |  From PhRMA

Research does not end once a medicine is approved by the U.S. Food and Drug Administration; it is built upon to improve outcomes for patients, simplify treatment regimens and monitor safety. America’s biopharmaceutical research companies are committed to a dynamic research ecosystem that delivers...

Forced pharmaceutical localization fails to deliver

PhRMA  |  Blog Post

This, despite the fact that many of these countries exhibit some of the strongest biopharmaceutical market growth rates as well as significant market size and potential.

Jessica Melore

PhRMA  |  Biography

She is also member of the National Kidney Foundation’s transAction executive committee.

PhRMA’s John Castellani Gives Attendees a 2015 Leukemia Ball Sneak Peek

PhRMA  |  Blog Post

They are nothing short of inspirational and the reason this work is so important.

Medicare Monday: What is CMMI?

PhRMA  |  Blog Post

Earlier this year, Medicare set a goal of moving 50 percent of payments into APMs by 2018.

Patience, Hope and Survival: Progress on the Cancer Front

PhRMA  |  Blog Post

I am proud to be part of this discussion to seek pathways forward and improve the future for cancer patients.

New Report Reveals Growth Trajectories and Top Policy Factors Affecting Biopharmaceutical Innovation & Growth

PhRMA  |  Press Release

In fact, the Congressional Budget Office (CBO) recently adopted an historic scoring change that credits Medicare policies that increase use of medicines with savings on other Medicare costs.

Impact of deductibles in health plans

PhRMA  |  Blog Post

We’ve seen reports on the use of high deductibles that include prescription drugs in health insurance exchange plans and the

TPP's Outcome Pivotal For Future Of Global Biomedical Innovation

From Hope To Cures  |  From Our Network

examined the effect of pharmaceutical patent protection on the speed of drug launch, price, and quantity around the world and has found that stronger IP rights can increase the availability of new treatments to patient populations in developing countries.

You have reviewed the first 425 results out of 1200. Each page contains 25 results. You're on page 17.

prev 13 14 15 16 17 18 next